Indication
Facial squamous cell carcinoma
1 clinical trial
1 product
Product
STP705Clinical trial
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Subjects With Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)Status: Completed, Estimated PCD: 2023-03-29